Drug eluted vascular graft
OwnerSamuel J. Wonginventor
Life of this patent
Estimating the term…
Abstract
A drug Eluted vascular graft where the internal lumen are coated with at least one or more bioerodible polymers capable of releasing at least one or more therapeutic agents in a controlled time-released manner. The therapeutic agent may include an antimicrotubule, an antiproliferative agent, or an antithrombogenic agent. A method for preventing thrombosis of vascular grafts used in vascular access for hemodialysis, vascular reconstruction and coronary bypass grafting.
Claims22
A drug eluting vascular graft for the controlled and sustained delivery of at least one therapeutic agent within the internal lumen of the vascular graft.
5 The drug eluting vascular graft of claim 1, wherein said vascular graft may be comprised of expanded polytetrafluroethylene (ePTFE), polyvinylchloride polypropylene, florinated ethylene propylene, polyetherurethaneura or other biocompatible plastics.
6 The drug eluting vascular graft of claim 1, wherein said vascular graft may be of various diameters and lengths.
7 The drug eluting vascular graft of claim 1, wherein at least one polymer is a polyester.
The drug eluting vascular graft in claim one, wherein microcapsules of said therapeutic agents are dispersed within said polymers.
A method for preventing or thrombosis of vascular grafts.
A method for preventing stenosis of vascular grafts.
An improved vascular graft used in vascular access for hemodialysis.
An improved vascular graft used in vascular reconstruction.
An improved vascular graft used in the treatment of coronary artery disease.
Dependencies are inferred from the claim text.